Par Pharmaceutical Companies, Inc.’s seasoned corporate management team has a broad range of expertise and a commitment to developing, manufacturing, marketing and distributing safe, innovative and quality pharmaceuticals.

Paul V. Campanelli
Chief Executive Officer, Par Pharmaceutical Companies, Inc.

Mr. Campanelli was promoted to Chief Executive Officer in September 2012, following the completion of the Company’s acquisition by TPG. Prior to the acquisition, Mr. Campanelli, has served as Chief Operating Officer and President, Par Pharmaceutical (generics division) and had responsibility for Strativa Pharmaceuticals (branded division). He began his career at Par in 2001 and was elected by the board of directors as a corporate officer in 2007. Mr. Campanelli was Vice President, Business Development at Dr Reddy Labs, where he worked from 1992 – 2001.

Terrance J. Coughlin
Chief Operating Officer, Par Pharmaceutical Companies, Inc.

Mr. Coughlin has served as Chief Operating Officer since joining the company in April 2014. Prior to joining Par, he served as president and chief executive officer of Glenmark Generics, Inc. USA/Glenmark Generics Limited. Prior to Glenmark, Mr. Coughlin was senior vice president at Dr. Reddy’s Laboratories, Inc. His more than 25 years of pharmaceutical industry experience extends from API to finished dosage, and from R&D to sales and marketing. Mr. Coughlin has managed businesses, including manufacturing facilities, in the U.S. and abroad.

Thomas J. Haughey
General Counsel and Chief Administrative Officer

Mr. Haughey has served as Chief Administrative Officer since 2008, Executive Vice President since 2006 and General Counsel and Secretary since joining Par in 2003. Prior to Par, he served as legal counsel to various areas of Schering-Plough Corporation, including licensing, research and business development. Mr. Haughey is also a certified public accountant and brings 30 years of accounting, legal and pharmaceutical experience to his current role at Par.

Michael A. Tropiano
Executive Vice President and Chief Financial Officer

Mr. Tropiano was named Executive Vice President and Chief Financial Officer in July 2010. He joined Par as Vice President and Treasurer in August of 2005. Prior to joining Par, Mr. Tropiano served as Vice President and Corporate Treasurer of MedPointe Pharmaceuticals from 2001 to 2005 and Assistant Treasurer at Carter-Wallace from 1984 to 2001. He earned his Masters of Business Administration in Finance from Fordham University and a Bachelors of Arts in Economics from Siena College. He is also a Chartered Financial Consultant.